Form 4: Hologic COO Sells Shares for Tax Obligations

Hologic's Chief Operating Officer, Essex D. Mitchell, disposed of 1,342 shares of common stock to cover tax obligations related to restricted unit vesting.

Summary

• Essex D. Mitchell, Chief Operating Officer of Hologic Inc. (HOLX), reported a transaction involving the disposal of common stock.
• The transaction occurred on November 14, 2025, and involved 1,342 shares of Hologic common stock.
• The shares were disposed of at a price of $74.15 per share.
• This disposal was for shares withheld to cover tax obligations associated with the settlement of restricted units, for which service-based vesting requirements had been satisfied.
• Following this transaction, Mr. Mitchell beneficially owns 77,610 shares of Hologic common stock directly.
• The transaction was made pursuant to a Rule 10b5-1(c) pre-planned contract, instruction, or written plan.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary insider transaction for tax purposes, which is neutral in sentiment and does not indicate any positive or negative operational or financial developments for the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, which is common across all industries for publicly traded companies. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence or company fundamentals.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by a Chief Operating Officer to cover tax obligations arising from restricted stock unit vesting. Such transactions, especially when executed under a Rule 10b5-1 plan, are common and do not typically reflect a change in the executive's outlook on the company's prospects or fundamental value. Therefore, this specific filing provides no new information that would warrant a change in investment recommendation; a 'hold' stance is maintained based solely on this report.

Keywords

Hologic, HOLX, Form 4, Insider Transaction, Stock Sale, Executive Compensation, Tax Withholding, Restricted Stock Units, Rule 10b5-1